After a false state earlier this year, Canadian cannabis retailer High Tide said Thursday it will finally enter German medical marijuana market.
In a 27.2 million-euro deal ($31.7 million), High Tide will acquire 51% of Remexian Pharma GmbH, an established pharmaceutical company created to import and wholesale medical marijuana.
ADVERTISEMENT
The deal follows an earlier move for a German company High Tide announced and abandoned earlier this year.
“Remexian is an ideal match for us – not only in its commitment to discount pricing but also in its operational approach, which mirrors our lowest price guarantee in Canada,” High Tide founder and CEO Raj Grover said.
“We took our time evaluating potential partners and couldn’t be more excited to join forces with the best-in-class
Read full article on Marijuana Business Daily
